Columbus McKinnon (CMCO) director awarded additional deferred stock units

Rhea-AI Filing Summary

Columbus McKinnon director Kathryn V. Bohl reported multiple acquisitions of deferred stock units tied to company common shares. On February 23, 2026, she received a total of 72.2635 deferred stock units through grants classified as “grant, award, or other acquisition,” at a stated price of $0.0000 per unit, primarily attributable to dividend reinvestment. Each deferred stock unit equals one share of Columbus McKinnon common stock, and the deferred shares will be delivered after she ceases to be a director under the applicable plan. Following these transactions, she also directly holds 14,812 shares of common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bohl Kathryn V

(Last) (First) (Middle)

13320 BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLUMBUS MCKINNON CORP [ CMCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								14,812	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(1)	02/23/2026		A		15.3559(2)		(3)	(3)	Common Stock	4,260.164	$0	4,275.5199(3)	D
Deferred Stock	(1)	02/23/2026		A		11.8335(2)		(3)	(3)	Common Stock	3,256.829	$0	3,268.6625(3)	D
Deferred Stock	(1)	02/23/2026		A		13.1259(2)		(3)	(3)	Common Stock	3,587.5867	$0	3,600.7126(3)	D
Deferred Stock	(1)	02/23/2026		A		31.9482(2)		(3)	(3)	Common Stock	8,635.0466	$0	8,666.9948(3)	D

Explanation of Responses:

1. Each deferred stock unit is equal in value to one share of Columbus McKinnon Corporation common stock.

2. Represents additional deferred stock units attributable to dividend reinvestment.

3. Deferred shares will be delivered after the reporting person ceases to be a director of issuer, under and subject to the terms of the Plan.

Remarks:

	Mary C. O'Connor, Power of Attorney for Kathryn Bohl	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Columbus McKinnon (CMCO) report for Kathryn V. Bohl?

Kathryn V. Bohl, a director of Columbus McKinnon, reported acquiring deferred stock units on February 23, 2026. These units were recorded as grants or awards, largely tied to dividend reinvestment, and are economically equivalent to shares of common stock under the company’s plan.

How many deferred stock units did CMCO director Kathryn Bohl acquire in this Form 4?

Kathryn Bohl acquired 72.2635 deferred stock units in several small grant transactions. Each unit equals one share of Columbus McKinnon common stock, reflecting additional director compensation credited under the company’s plan and associated dividend reinvestment mechanism.

What is the nature of the deferred stock units reported by CMCO for Kathryn Bohl?

The deferred stock units are compensation instruments equal in value to one CMCO common share. They are credited to the director’s account, including amounts attributable to dividend reinvestment, and will be delivered only after she ceases serving as a director, consistent with the governing plan.

When will Kathryn Bohl receive the CMCO deferred shares reported in this filing?

The deferred shares will be delivered after Kathryn Bohl ceases to be a director. Until then, they remain as deferred stock units under the company’s plan, with value tied to Columbus McKinnon common stock and credits including dividend reinvestment amounts.

Did Kathryn Bohl buy or sell Columbus McKinnon (CMCO) common stock on the open market?

The Form 4 shows grant or award acquisitions of deferred stock units, not open-market purchases or sales. Transactions are coded as awards at a stated price of $0.0000 per unit, reflecting non-cash director compensation and dividend reinvestment credits under the company’s plan.

How many CMCO common shares does Kathryn Bohl hold directly after these transactions?

After the reported transactions, Kathryn Bohl directly holds 14,812 shares of Columbus McKinnon common stock. This direct holding is separate from her deferred stock units, which are scheduled for delivery only after she no longer serves as a director.